Article

Biosyntrx dietary supplement intended to enhance eye health

Biosyntrx this week unveiled ZoOmega-3, a concentrated dietary supplement produced from cold-water fish. ZoOmega-3 is intended to enhance eye and body health and disease prevention.

Chicago-Biosyntrx this week unveiled ZoOmega-3, a concentrated dietary supplement produced from cold-water fish. ZoOmega-3 is intended to enhance eye and body health and disease prevention.

Each capsule of ZoOmega-3 contains 300 mg of ethyl EPA Omega-3 fatty acid, suggested to appropriately inhibit the downstream metabolism of Omega 7 fatty acids, preventing excessive production of pro-inflammatory prostaglandins, which have been suggested in the literature to contribute to silent inflammation when not kept in check.

In addition, each ZoOmega-3 capsule also includes 200 mg of ethyl DHA, another Omega-3 fatty acid, suggested to increase cellular permeability, allowing nutrients such as amino acids, antioxidants, enzymes, vitamins, and minerals to enter cells to address free radical damage and oxidation, as well as to protect mitochondria DNA.

“Excessive amounts of Omega-3 fatty acid can interfere with the body’s ability to mount a life-saving inflammatory response when needed, such as fevers to combat viral or bacterial attack, swelling to protect broken bones, or clotting to stop bleeding,” said Spencer Thornton, MD, president, chief medical officer, and one of the Biosyntrx founders.

Dr. Thornton went on to explain that Biosyntrx recommends one ZoOmega-3 capsule a day for health maintenance and disease prevention, particularly on days that fish is not included in the diet. 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Dr. Wendy Lee at Controversies in Modern Eyecare 2025
I. Paul Singh, MD, speaks about glaucoma treatment and successful ophthalmic / optometric comanagement at the 19th Annual Controversies in Modern Eye Care meeting
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
© 2025 MJH Life Sciences

All rights reserved.